(0.12%) 5 303.27 points
(0.34%) 40 004 points
(-0.07%) 16 686 points
(0.97%) $80.00
(5.73%) $2.64
(1.44%) $2 419.80
(6.36%) $31.78
(2.18%) $1 094.70
(-0.02%) $0.920
(-0.18%) $10.68
(-0.27%) $0.787
(0.19%) $91.05
Live Chart Being Loaded With Signals
Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia; Carglumic Acid for the treatment of acute and chronic hyperammonemia due to N-acetylglutamate Synthase deficiency; and Rezipres, a ready-to-use formulation of a molecule that is indicated for the treatment of clinically important hypotension occurring in the setting of anesthesia...
Stats | |
---|---|
本日の出来高 | 25 959.00 |
平均出来高 | 63 919.00 |
時価総額 | 93.00M |
EPS | $0 ( 2024-05-13 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -90.50 |
ATR14 | $0.0120 (0.33%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-02-13 | Gruber James R. | Buy | 144 677 | Stock Option (Right to buy) |
2024-02-13 | Adams Jennifer Mckie | Buy | 30 000 | Stock Option (Right to buy) |
2024-02-13 | Brynjelsen Sean | Buy | 438 633 | Stock Option (Right to buy) |
2024-02-13 | Casamento Charles J | Buy | 30 000 | Stock Option (Right to buy) |
2024-02-13 | Krempa David | Buy | 144 677 | Stock Option (Right to buy) |
INSIDER POWER |
---|
56.09 |
Last 96 transactions |
Buy: 4 266 352 | Sell: 3 981 653 |
ボリューム 相関
Eton Pharmaceuticals Inc 相関
10 最も正の相関 |
---|
10 最も負の相関 |
---|
知っていましたか?
相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。
相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。
Eton Pharmaceuticals Inc 相関 - 通貨/商品
Eton Pharmaceuticals Inc 財務諸表
Annual | 2023 |
収益: | $31.64M |
総利益: | $21.06M (66.56 %) |
EPS: | $-0.0365 |
FY | 2023 |
収益: | $31.64M |
総利益: | $21.06M (66.56 %) |
EPS: | $-0.0365 |
FY | 2022 |
収益: | $21.25M |
総利益: | $14.32M (67.38 %) |
EPS: | $-0.390 |
FY | 2021 |
収益: | $21.83M |
総利益: | $19.21M (87.99 %) |
EPS: | $-0.0800 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Eton Pharmaceuticals Inc
Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia; Carglumic Acid for the treatment of acute and chronic hyperammonemia due to N-acetylglutamate Synthase deficiency; and Rezipres, a ready-to-use formulation of a molecule that is indicated for the treatment of clinically important hypotension occurring in the setting of anesthesia. It also offers Alkindi Sprinkle, a replacement therapy for adrenocortical insufficiency in children under 17 years of age; EPRONTIA, a liquid formulation of topiramate; and Alaway Preservative Free, a preservative-free ophthalmic product to treat allergic conjunctivitis. In addition, the company develops Zonisamide Oral Suspension for the treatment of partial on-set seizures; Lamotrigine for Oral Suspension for the treatment of partial on-set seizures; cysteine injection; dehydrated alcohol injection; and Zeneo hydrocortisone autoinjector. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois.
について ライブシグナル
このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。